Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Danazol for heavy menstrual bleeding.

H Beaumont1, C Augood, K Duckitt

  • 13 Hazelhurst Road, Llandafff, Cardiff, Wales, UK, CF14 2FW. beaumont@cardiff.ac.uk

The Cochrane Database of Systematic Reviews
|June 22, 2002
PubMed
Summary

Danazol effectively reduces heavy menstrual bleeding (HMB) compared to other medical treatments, but its use may be limited by side effects and uncertain acceptability. Further research is needed due to small trial sizes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tau positron emission tomography imaging in C9orf72 repeat expansion carriers.

European journal of neurology·2019
Same author

Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis.

Acta psychiatrica Scandinavica·2014
Same author

Localization of mGluR5, GABAB, GABAA, and cannabinoid receptors on the vago-vagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study.

Neurogastroenterology and motility·2012
Same author

Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations.

Allergy·2011
Same author

The GABA(B) receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study.

Alimentary pharmacology & therapeutics·2009
Same author

Association of diabetes with age-related macular degeneration in the EUREYE study.

The British journal of ophthalmology·2009

Area of Science:

  • Gynecology
  • Pharmacology

Background:

  • Heavy menstrual bleeding (HMB) significantly impacts premenopausal women's health.
  • Medical therapies are preferred over surgery, but treatment effectiveness varies.
  • Danazol, a synthetic steroid, induces endometrial atrophy, reducing menstrual loss.

Purpose of the Study:

  • To evaluate the effectiveness and tolerability of danazol for treating heavy menstrual bleeding in reproductive-aged women.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) identified through comprehensive electronic searches.
  • Included trials compared danazol against placebo, other medical therapies, or different danazol dosages.
  • Data extraction focused on menstrual blood loss, adverse events, weight gain, and treatment withdrawal.

Related Experiment Videos

Main Results:

  • Danazol demonstrated greater efficacy than placebo, progestogens, NSAIDs, and oral contraceptive pills (OCP) in reducing menstrual blood loss (MBL).
  • Danazol treatment resulted in more adverse events compared to NSAIDs and progestogens, though adherence was not significantly affected.
  • Danazol significantly reduced the duration of menses compared to NSAIDs and progesterone-releasing IUDs.

Conclusions:

  • Danazol appears effective for HMB but its clinical utility is limited by side effects and uncertain patient acceptability.
  • The small number and sample sizes of included trials prevent strong recommendations.
  • Further research is required to fully ascertain danazol's role in managing HMB.